Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs

Author(s): Cristina Bischin, Alexandru Lupan, Vicentiu Taciuc, Radu Silaghi-Dumitrescu

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 11 , Issue 3 , 2011

Become EABM
Become Reviewer


Cisplatin and its congeners are well-known to exert their therapeutic effects on cancer via interaction with DNA in the cell nucleus. On the other hand, the undesirable side-effects of these drugs appear to also be linked, at least to some extent, to interaction of the platinum with proteins and peptides. For other classes of anticancer drugs, interaction with proteins is in fact the primary pathway whereby therapeutically-useful effects are achieved. Here, a review is given of the known instances of interaction of cisplatin and related compounds with proteins and biologically relevant peptides, with emphasis on structural and reactivity aspects.

Keywords: Cisplatin, cysteine, methionine, adduct, toxicity, resistance, Interactions, Proteins, Platinum, Anti-Cancer, DNA, peptides, DNA-Processing Enzymes, Platinum-Binding Proteins

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [214 - 224]
Pages: 11
DOI: 10.2174/138955711795049844
Price: $65

Article Metrics

PDF: 9